Keywords: Bristol-Myers Squibb, Pfizer, Eliquis, USA, FDA, Stroke prevention, Atrial fibrillation
US FDA finally approves Bristol-Myers/Pfizer's Eliquis for stroke prevention in AF patients
Article | 31 December 2012
The US Food and Drug Administration on December 28 finally approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
